Skye Bioscience (SKYE) Stock Price, Quote, News & History | Benzinga

Skye Bioscience Inc (SKYE) Stock Price, Quote, News & History

SKYENASDAQ

Trade with Public

Trade with Public

$0.3059

-0.0531-14.79%

At close: Aug 18, 5:00 PM EST

$0.3393

-0.0197-5.49%

Pre-Market: 6:25 AM EST

Earnings: Q2 2026 Earnings were released on Fri Aug 14th, during market hours

M&A: Redx Pharma Limited announced it will be acquired by Skye Bioscience (SKYE) on Friday, August 14, 2026

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$0.31

Volume / Avg.

20.68K / 443.21K

Day Range

- - -

52 Wk Range

0.28 - 4.99

Market Cap

$12.02M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

25

Short Interest

5.2%

Days to Cover

12.56

Recent Skye Bioscience Inc News

Why HIVE Digital Technologies Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

HIVE Digital Technologies Ltd (NASDAQ: HIVE) rose in pre-market trading due to its subsidiary's new agreement. Other gainers include IP Strategy Holdings, INVO Fertility, My Size, Trugolf Holdings, Expion360, Skye Bioscience, Julong Holding, FIEE Inc, and Keel Infrastructure. Losers include Generation Income Properties, Barfresh Food Group, iTonic Holdings, Akanda Corp, and Reservoir Media.

Avi Kapoor

Why Domo Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket

Domo Inc (DOMO) stock jumped 48.8% in pre-market trading after beating Q4 earnings expectations by 117.65% and reporting a rise in revenue.

Avi Kapoor

Penny Stock Skye Bioscience Drug Combo With Wegovy Shows Over 22% Weight Loss After One Year

Skye Bioscience reports Phase 2a data showing nimacimab plus semaglutide led to over 22% weight loss at 52 weeks, with lower weight regain and no serious safety issues.

Vandana Singh

Why Multi Ways Holdings Shares Are Trading Higher By Around 60%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Nasdaq Jumps Over 150 Points; Skye Bioscience Shares Plunge

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-38.81M

Investing Cash Flow (TTM)

23.20M

Financing Cash Flow (TTM)

-161.13K

Free Cash Flow (TTM)

-38.81M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-15.77M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.36M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-403.15%

Earnings Yield % (FWD)

-437.80%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.01

Company Debt

Total Debt

$143.05K

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$8.07M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$0.31

Volume / Avg.

20.68K / 443.21K

Day Range

- - -

52 Wk Range

0.28 - 4.99

Market Cap

$12.02M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

25

Short Interest

5.2%

Days to Cover

12.56

About

Sector

Health Care

Industry

Biotechnology

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Skye Bioscience (SKYE) stock?

A

You can purchase shares of Skye Bioscience (NASDAQ:SKYE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Skye Bioscience (SKYE) competitors?

A

Other companies in Skye Bioscience’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Skye Bioscience (SKYE) stock?

A

Skye Bioscience has a consensus price target of $17.00.

Q

What is the current price for Skye Bioscience (SKYE)?

A

The stock price for Skye Bioscience (NASDAQ: SKYE) is $0.3393 last updated August 20, 2026 at 6:26 AM EDT.

Q

Does Skye Bioscience (SKYE) pay a dividend?

A

There are no upcoming dividends for Skye Bioscience.

Q

When is Skye Bioscience (NASDAQ:SKYE) reporting earnings?

A

Skye Bioscience does not have any upcoming earnings scheduled.

Q

Is Skye Bioscience (SKYE) going to split?

A

There is no upcoming split for Skye Bioscience.

Q

What sector and industry does Skye Bioscience (SKYE) operate in?

A

Skye Bioscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.